Cargando…

Response

Detalles Bibliográficos
Autores principales:	Sweiss, Nadera J., Korsten, Peter, Baughman, Robert P., Culver, Daniel A., Judson, Marc A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930724/ https://www.ncbi.nlm.nih.gov/pubmed/33678263 http://dx.doi.org/10.1016/j.chest.2020.10.005

Ejemplares similares

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

Editorial: Sarcoidosis—The great mimicker
por: Korsten, Peter, et al.
Publicado: (2022)

Management of extrapulmonary sarcoidosis: challenges and solutions
por: Al-Kofahi, Khalid, et al.
Publicado: (2016)

Activity tracking devices in sarcoidosis
por: Klein, Rebecca A., et al.
Publicado: (2023)

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review
por: Sweis, Jaleel Jerry G., et al.
Publicado: (2022)

Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case report
por: Patschan, Daniel, et al.
Publicado: (2011)

When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic
por: Sweiss, Nadera J., et al.
Publicado: (2020)

Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: Results of a self-reporting questionnaire
por: Vagts, Christen, et al.
Publicado: (2023)

Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study
por: Korsten, Peter, et al.
Publicado: (2017)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Reproducibility and rigor in rheumatology research
por: Alnaimat, Fatima, et al.
Publicado: (2023)

Corrigendum: Reproducibility and rigor in rheumatology research
por: Alnaimat, Fatima, et al.
Publicado: (2023)

Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial
por: Baughman, Robert P, et al.
Publicado: (2021)

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
por: Baughman, Robert P., et al.
Publicado: (2020)

Efzofitimod for the Treatment of Pulmonary Sarcoidosis
por: Culver, Daniel A., et al.
Publicado: (2023)

Reply to Nett et al.: Collecting Occupational Exposure Data Would Strengthen Idiopathic Pulmonary Fibrosis Registries
por: Culver, Daniel A., et al.
Publicado: (2020)

Treatment of Periorbital Edema in a Patient With Systemic Lupus Erythematosus During Pregnancy: A Case Report Written With the Assistance of ChatGPT
por: Jansz, Jacqueline, et al.
Publicado: (2023)

Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT
por: Jansz, Jacqueline, et al.
Publicado: (2023)

Letter from New Castle, Ky.
por: Culver, C. P.
Publicado: (1853)

Reply to Sanyal et al.: Overlooked Role of Histopathology in Evaluations for Occupational/Environmental Exposures
por: Culver, Daniel A., et al.
Publicado: (2020)

Reply to P. B. et al., to Fahim and Rosewarne, and to Reich
por: Patterson, Karen C., et al.
Publicado: (2020)

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
por: Aronov, Avi, et al.
Publicado: (2022)

Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT
por: Vagts, Christen, et al.
Publicado: (2021)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Full-Thickness Eyelid Lesions in Sarcoidosis
por: Collins, Megan E., et al.
Publicado: (2013)

Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations
por: Sweiss, Nadera J., et al.
Publicado: (2010)

Correction: Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations
por: Sweiss, Nadera J., et al.
Publicado: (2010)

Expansion of a Novel Subset of PD1+CXCR5-CD4+ T Peripheral Helper Cells in IgG4-Related Disease
por: Cargill, Tamsin, et al.
Publicado: (2020)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
por: Saketkoo, Lesley Ann, et al.
Publicado: (2021)

Exposure to occupational antigens might predispose to IgG4‐related disease
por: de Buy Wenniger, Lucas J. Maillette, et al.
Publicado: (2014)

Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients
por: Mirsaeidi, Mehdi, et al.
Publicado: (2016)

Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy
por: Syed, Huzaefah, et al.
Publicado: (2020)

Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
por: Sweiss, Nadera J., et al.
Publicado: (2011)

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Treatment of COVID-19 in Patients With Sarcoidosis
por: Kondle, Shreya, et al.
Publicado: (2021)

Response
por: Adams, Hugo J.A., et al.
Publicado: (2021)

There Is No Such Thing as a Psychiatric Disorder/Disease/Chemical Imbalance
por: Baughman, Fred
Publicado: (2006)

Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis
por: Drake, Wonder P., et al.
Publicado: (2021)

Response to Wang and Luo
por: Rehmsmeier, Marc
Publicado: (2012)

Response
por: Okin, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i4cga0vrdp8n98sn07ongorcki